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Genomic Sequence Analysis of the Mouse Desmoglein
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Characterization of Mouse DSG4, DSG5, and DSG6
Neil Vincent Whittock
The desmosomal cadherins, comprising the desmogleins and desmocollins, are calcium-dependent transmembrane
adhesion molecules that are essential for the cell adhesive role of desmosomes. Until recently, three mouse and three
human desmoglein isoforms had been characterized that are expressed in a tissue- and differentiation-specific manner. Very
recently, however, we revealed genetic evidence for the presence of a fourth human gene, DSG4. Here we present genetic
evidence for the mouse DSG4 homolog as well as two additional novel mouse desmoglein genes situated within the mouse
cluster. We have named these two new genes DSG5 and DSG6, both of which demonstrate close homology with mouse
DSG1. Mouse DSG4 comprises 16 exons spanning 36 kb of 18q, whereas DSG5 and DSG6 comprise 15 exons spanning
approximately 33 and 37 kb, respectively, of 18q. The mouse desmoglein 4 transcript contains an open reading frame of
3123bp, encoding a precursor of 1041 amino acids. The desmoglein 5 transcript contains an open reading frame of 3180bp
encoding a precursor of 1060 amino acid residues, and the desmoglein 6 transcript contains an open reading frame of
2733bp encoding a precursor of 911 amino acid residues. Using mouse tissue cDNA we have demonstrated that mouse
desmogleins 4, 5, and 6 are all expressed in the epidermis but are expressed during different times of mouse development.
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The desmogleins and desmocollins, termed the desmosomal cadher-
ins, are members of the cadherin superfamily. This superfamily
comprises at least six subfamilies based on gene organization, protein
domain composition, and phylogenetic analysis of their protein
sequences (Nollet et al, 2000). The subfamilies comprise the type I
classical cadherins, the type II atypical cadherins, desmocollins,
desmogleins, protocadherins, and Flamingo cadherins. Initial experi-
ments on bovine muzzle epidermis, a tissue rich in desmosomes,
identified a constitutive transmembrane glycoprotein that was named
‘‘desmoglein’’ (also known as band 3 protein) (Schmelz et al, 1986).
Using the antibodies raised against this bovine desmoglein further
studies identified the cDNA and protein sequence of bovine
desmoglein 1 (Koch et al, 1990; 1991). Similar to the classical
cadherins, the desmosomal cadherins contain five homologous
extracellular domains, a single transmembrane spanning domain,
and a carboxy-terminal intracellular tail (Koch et al, 1990; Wheeler
et al, 1991). The amino-terminal regions of the desmogleins and
desmocollins make up the extracellular core domain of the desmo-
some (North et al, 1999). Calcium-dependent heterophilic adhesion
occurs between the desmocollins and desmogleins of different cells, in
addition to some homophilic adhesion (Chitaev and Troyanovsky,
1997; Marcozzi et al, 1998; Tselepis et al, 1998). In particular, studies
have demonstrated that the first two extracellular domains (EC1 and
EC2) of dcsmocol-lin are necessary for heterophilic binding to the first
three extracellular domains of desmoglein (EC1—3) (Chitaev and
Troyanovsky, 1997). Recent work on the adhesive ability of the first
two extracellular domains of desmocollin 2 and desmoglein 2 has
shown that desmocollin 2 can form homophilic interactions as well as
calcium-dependent heterophilic reactions with desmoglein 2, whereas
desmoglein 2 demonstrates a much weaker ability to form homophilic
interactions (Syed et al, 2002). These results therefore suggest that both
desmoglein and desmocollin isoforms are required in the same cell for
optimal cell adhesion.
Within the desmosome the intracellular tails of the desmogleins
and desmocollins bind the ‘‘arm’’ repeat domain of plakoglobin
(Kapprell et al, 1988; Troyanovsky et al, 1993, 1994a; 1994b; 1996;
Mathur et al, 1994; Ozawa et al, 1995; Wahl et al, 1996; Witcher
et al, 1996; Andl and Stanley, 2001). Early studies suggested that,
although desmocollins could bind only one molecule of plakoglobin,
the desmogleins could bind six to seven plakoglobin molecules
(Kowalczyk et al, 1996; Witcher et al, 1996). This is now in doubt as a
recent study has shown that the desmogleins bind no more than one or
two plakoglobin molecules in an isoform-spe-cific manner (Bannon
et al, 2001).
Extensive work on several species including mice, cows, and
humans revealed that there were three different isoforms of both the
desmogleins and desmocollins although the desmocollins can exist in
a and b forms (Buxton et al, 1993). Desmoglein 2 and desmocollin 2
appear to be the largest isoforms and are the essential desmosomal
cadherins common to all desmosome-posscssing tissues, including
simple epithelia, myocardium, and cell cultures (Koch et al, 1992;
Theis et al, 1993; Schmidt et al, 1994). In contrast, the epidermal
isoforms desmogleins 1 and 3, and desmocollins 1 and 3 are restricted
to certain specialized epithelia (Koch et al, 1992; Schafer et al, 1994;
1996; Schmidt et al, 1994). Within the epidermis the desmosomal
cadherin isoforms are expressed in a differentiation-specific manner,
with desmoglein 1 and desmocollin 1 being upper spinous and
granular layer, desmoglein 2 and desmocollin 2 being basal, and
desmoglein 3 and desmocollin 3 being basal layer and first suprabasal
layer (Arnemann et al, 1993; King et al, 1993; 1995; Theis et al, 1993;
Schmidt et al, 1994; Nuber et al, 1995; Yue et al, 1995; Adams et al,
1998; Denning et al, 1998). The isoform of desmosomal cadherin
present in individual des-mosomes relies upon whether the desmo-
some is in a region where the territories of the individual isoforms
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overlap or not. In a study on desmocollins 1 and 3 it was shown that
the ratio of proteins within an individual dcsmosome alters gradually
from the basal to immediate suprabasal and then the upper suprabasal
layer (North et al, 1996), demonstrating that epidermal cells are
continually modified as they climb through the epidermis with a
continual turnover of desmosomal cadherin protein. In mouse
development the ratio of desmocollin 1 to desmocollin 3 expression
throughout the different layers in the epidermis is crucial to establishing
the correct pattern of differentiation, and that the establishment of the
adult pattern of desmocollin expression corresponds to the adult pattern
of epidermal stratification (King et al, 1996; Chidgey et al, 1997).
Recently, we have shown genetic evidence for an additional
desmoglein isoform in the human genome, which we have termed
desmoglein 4 (Whittock and Bower, 2003), which demonstrates highest
homology to desmoglein 3. Here we reveal genetic evidence for the
mouse desmoglein 4 homolog as well as two additional mouse
desmoglein isoforms that we term desmoglein 5 and desmoglein 6
and we demonstrate their specific tissue expression, in addition to
reviewing the properties of the mouse desmogleins.
MATERIALS AND METHODS
Reverse transcription polymerase chain reaction (RT-PCR) and cDNA
expression studies
Total RNA was extracted from adult mouse skin using the Perfect RNA kit (Eppendorf
AG, Cambridge, UK) as per the manufacturer’s instructions. RNA was reverse
transcribed using random hexamer primers with the Thcrmo-script cDNA kit
(Invitrogen, Paisley, UK) as per the manufacturer0s instructions. First strand cDNA
from mouse skin and multiple mouse tissues (BD Clontech, Basingstoke, UK) was used
for PCR using intron crossing primers. The gene-specific pnmers used for RT-PCR in
cDNA expression studies of desmoglein 1 were DSG1F (forward-situated in exon 11) 50-
GGC ACT TCT TCC ACT GAG AA-30 and DSG1R (reverse-situated in exon 12) 50-CAG
ATC AGC AGG AAT GGA ACC-30. Primers used for amplification of desmoglein 2
were DSG2F (forward-situated in exon 12) 50-GTG TGG CTG CAC AGT ATG AC-30
and DSG2R (reverse-situated in exon 14) 50-CAT GCC TTC CTT GAG CAT CG-30.
Primers used for amplification of desmoglein 3 were DSG3F (forward-situated in exon
12) 50-CCT GAC AGT GTG TCA ATG TG-30 and DSG3R (reverse-situated in exon 13)
50-GGC TGA GCT CCT TCG ATT CC-30. Primers used for desmoglein 4 expression
studies were DSG4F (forward-situated in exon 4) 50-GCG GGG ATT GAT CGG CCA
CC-30 and DSG4R (reverse-situated in exon 7) 50-CTT GAT TCT GCA GTC ACA TTC-
30. Primers used for expression studies of desmoglein 5 were DSG5F (forward-situated
in exon 11) 50-CAA GGC ACT TCT ACT GTG GG-30 and DSG5R (reverse-situated in
exon 12) 50-CAG ATC AGC AGG AAT GGA ACC-30. Primers used for expression
studies of desmoglein 6 were DSG6F (forward-situated in exon 9) 50-CAG GTC AAG
CTA CAA ACA AG-30 and DSG6R (reverse-situated in exon 11) 50-GTA CCA TGA TGA
TTG TCC CTG-30. Primers used to amplify glyccraldehyde-3-phosphate dehydrogen-
ase (GAPDH) were as supplied in the mouse tissue kit (BD Clontech). PCR was
performed in a 25 pi reaction mixture containing 10 pmol forward and reverse primers,
5 nmol each of dTTP, dCTP, and dATP, 3.8 nmol dGTP, 1.25 nmol dcaza GTP, 1.25 pi
dimethylsulfoxide, 25 pmol betaine, 10mM Tris–HC1, 50mM KC1, 1.5mM MgCl2, and
1.0U Amplitaq Gold Taq polymerase (Applied Biosystems, Warrington, UK). After an
initial denaturation of 951C for 12min, 30 cycles were performed of 951C for 1min,
551C for 1min, and 721C for 2min, with a final extension step of 721C for 10min. The
PCR products were examined by 1.5% agarose gel electrophoresis, purified using spin
columns (Qiagen, Crawley, UK), directly sequenced using Big Dye terminators on an
ABI 377 genetic analyzer (Applied Biosystems), and analyzed using Sequence
Navigator 1.0.1 software (Applied Biosystems).
RESULTS
Sequence analysis identifies the mouse DSG4 homolog
Analysis of the mouse genome sequence data in silico using the Blat
algorithm (http://genome.ucsc.edu) to find homology for human DSG4
(Whittock and Bower, 2003) was successful in characterizing the
majority of the mouse desmoglein 4 gene. In addition, the position of
the mouse homolog coincided with several predicted genes including
chrl8-197 (Gcneid), SMUST00000037563 (Enscmbl), chr18.21.011.a
(Twinscan), although some algorithms failed to predict a gene in this
region (Genie and Fgencshþ þ ). The mouse promoter and exon 1
were determined by analysis of HumMus.18.14381 as described for
the human gene (Whittock and Bower, 2003). Sequence analysis of
the mouse desmoglein 4 cDNA indicates a transcript of at least 3.5 kb
containing an open reading frame of 3123bp. Genomic organization
reveals that the mouse gene, like the human, is composed of 16 exons
spanning approximately 36 kb of mouse chromosome 18. The exons
varied from 36bp (exon 2) to 768bp coding (exon 16) in size, and the
introns varied from 9900bp (intron 1) to 152 bp (intron 13) in size
(Table I). The mouse coding region shares 82% nucleotide identity
with the human desmoglein 4 transcript (Whittock and Bower, 2003)
and 55% with mouse desmoglein 1 (Mahoney et al, 2002), 51% with
mouse desmoglein 2 (Mahoney et al, 2002), and 58% with mouse
desmoglein 3 (Ishikawa et al, 2000) (Table IV). Similar to the human
desmoglein genes, mouse DSG4 is more closely related to mouse
DSG3 as they both consist of 16 exons, whereas mouse DSG1 and
DSG2 comprise 15 exons. Sequence comparison for the human and
mouse DSG4 promoters reveals high homology and several common
binding sites for sex determining region Y gene product (SRY), AP-1,
CCAAT, enhancer binding protein, GATA binding factor, growth factor
independence 1, HNF-3/Fkh homolog 3, nuclear factor 1, and home-
odomain factor Nkx-2.5/csx.
Analysis of transcript, predicted protein, and tissue expression for
mouse desmoglein 4
The 3123bp open reading frame of the mouse desmoglein
4 cDNA encodes a precursor protein of 1041 residues with a
predicted molecular weight of 114,449Da and isoelectric point of
4.58 (Fig 1). Like the human desmoglein 4 protein this precursor
comprises a 21 amino acid signal sequence followed by a 28 amino
acid prosequence that includes an NXS/T glycosylation site and ends
in a basic putative proteolysis sequence RRQKR. Cleavage at this
sequence would result in a mature mouse desmoglein 4 unglycosy-
lated peptide of 992 amino acids with a molecular mass of 108,598Da
and an isoelectric point of 4.55. The extracellular region of mouse
desmoglein 4 (581 amino acids), by homology with other desmogle-
ins, is divided into four domains EC1—4, followed by an extracellular
anchor domain (EA). The conserved tripeptide sequence His-Ala-Val
of the typical cadhcrins, which is thought to be involved in cell
adhesion, is represented in mouse desmoglein 4 by the conservatively
substituted tripeptide sequence Arg-Ala-Leu. Additionally conserved
sequences in the extracellular domain of mouse desmoglein 4 and
other mouse desmogleins include putative Ca2þ binding motifs
(DXNDN and A/VXDXD) and two further potential N-glycosylation
sites (NXS/T), in EC1 that is conserved in the equivalent positions of
desmogleins 1–3, and in EA that is conserved only in desmoglein 3.
The extracellular domain is followed by a 25 amino acid predicted
transmembrane domain. The cytoplasmic domain of desmoglein 4
(386 amino acids) consists of an intracellular anchor domain, an
intracellular cadherin-typical segment, an intracellular linker domain, a
repeat unit domain, and a terminal domain. The repeat unit domain
contains one NVXVTE repeat and a highly related NVXYAE predicting
two repeats as found in desmoglein 3 (Fig 1). The overall identity at the
protein level of mouse desmoglein 4 with its human homolog (Whittock
and Bower, 2003) is 82% with 90% similarity. The identity of mouse
desmoglein 4 with mouse desmoglein 1 (Mahoney et al, 2002) is 42%,
with mouse desmoglein 2 (Mahoney et al, 2002) is 37%, and with mouse
desmoglein 3 (Ishikawa et al, 2000) is 47% (Table V). The expression
profile of the mouse desmoglein 4 transcript using RT-PCR demonstrates
expression in adult epidermis and whole embryo from gestational days 7
to 17. No expression was detected, however, in skeletal muscle, brain,
lung, liver, spleen, kidney, testis, or heart (Table VI).
Genomic sequence analysis reveals two further novel mouse
Desmogleins
During analysis of the annotated mouse genome data on chromosome
18 (http://genome.ucsc.edu) for the mouse homolog of human
desmoglein 4, several other predicted genes with homology to the
971
MOUSE DESMOGLEIN GENE CLUSTER
desmogleins were detected. These included one gene between the
mouse desmocollin gene cluster and mouse DSG1, with predicted
genes chrlS-194 (Geneid), Dir18.21.007.a (Twinscan), and
C18000206 (Fgeneshþ þ ), and another gene between DSG1 and
DSG4, with predicted genes chrl8-196 (Geneid), Chrl8.21.009.a
(Twinscan), and C18000209 (Fgenesh þ þ ). The genes predicted by
the various algorithms demonstrated varying levels of homology with
the known mouse desmoglein genes, DSG1–4. In addition, the
predicted mRNAs and proteins showed a high level of homology to
mouse desmogleins 1–4, specifically to desmoglein 1. To determine
whether these predicted genes were expressed and to confirm the
correct gene structure, overlapping RT-PCR was used on mouse
control cDNA.
Analysis of transcript, predicted protein, and tissue expression for
mouse desmoglein 5
Sequence analysis of the gene between DSG1 and DSG4, that we
name desmoglein 5, revealed a novel desmoglein with a transcript of
at least 3.4 kb containing an open reading frame of 3180bp. Exon-
intron organization demonstrated that the new gene, DSG5, com-
prised 15 exons spanning approximately 33 kb of mouse chromosome
18. The exons varied from 36bp (exon 2) to 1017bp coding (exon 15)
in size, and the introns varied from 291bp (intron 7) to 11,159bp
(intron 1) in size (Table II). Nucleotide homology of the mouse
desmoglein 5 open reading frame is 96% with mouse desmoglein 1
(Mahoney et al, 2002), 52% with mouse desmoglein 2 (Mahoney et al,
2002), 54% with mouse desmoglein 3 (Ishikawa et al, 2000), and 55%
with mouse desmoglein 4 (Table IV). The 3180bp open reading frame
encodes a precursor protein of 1060 residues with a predicted
molecular weight of 114,454Da and isoelectric point of 4.72 (Fig 1).
This precursor comprises a 21 amino acid signal sequence followed by
a 28 amino acid prosequence that includes an NXS/T glycosylation
site and ends in a basic putative proteolysis sequence RRQKR.
Cleavage at this sequence would result in a mature mouse desmoglein
5 unglycosylated peptide of 1011 amino acids with a molecular mass
of 108,628Da and an isoelectric point of 4.59. Within the
extracellular domain, the highly conserved tripeptide sequence His-
Ala-Val of the typical cadherins is represented in mouse desmoglein 5
by the conservatively substituted sequence Arg-Ala-Leu. In addition to
the conserved putative Ca2þ binding motifs (DXNDN and A/VXDXD),
there are three further potential N-glycosylation sites (NXS/T) in the
extracellular domain of mouse desmoglein 5, in EC1 that is conserved
in the equivalent positions of all mouse desmogleins, in EC2 that is
conserved in desmogleins 1 and 3, and in EA that is conserved only in
desmogleins 3 and 4 (Fig 1). The extracellular domain is followed by a
25 amino acid predicted transmembrane domain and a cytoplasmic
domain of which the repeat unit domain contains five NVXVT/RE
repeats (Fig 1). The protein identity of mouse desmoglein 5 with mouse
desmoglein 1 (Mahoney et al, 2002) is 94%, with mouse desmoglein 2
(Mahoney et al, 2002) is 34%, with mouse desmoglein 3 (Ishikawa
et al, 2000) is 44%, and with mouse desmoglein 4 is 42% (Table V).
The tissue expression profile determined by RT-PCR demonstrates that
mouse desmoglein 5 is expressed in adult epidermis and in developing
embryo day 17. Expression was not detected at embryonic days 7–15,
or in heart, whole brain, spleen, lung, liver, skeletal muscle, kidney, or
testis (Table VI).
Analysis of transcript, predicted protein, and tissue expression for
mouse desmoglein 6
Sequence analysis of the gene between the desmocollin gene cluster
and DSG1, which we name desmoglein 6, also revealed a novel
desmoglein with a transcript of at least 3.0 kb containing an open
reading frame of 2733bp. Exon–intron organization demonstrated that
DSG6 also comprised 15 exons spanning approximately 37 kb of
mouse chromosome 18. The exons varied from 36bp (exon 2) to
723bp coding (exon 15) in size, and the introns varied from 291bp
(intron 7) to 16,812bp (intron 1) in size (Table III). Homology at the
nucleotide level for the mouse desmoglein 6 open reading frame is
82% with mouse desmoglein 1 (Mahoney et al, 2002), 49% with
mouse desmoglein 2 (Mahoney et al, 2002), 55% with mouse
desmoglein 3 (Ishikawa et al, 2000), 55% with mouse desmoglein 4,
and 81% with mouse desmoglein 5 (Table IV). The 2733bp open
reading frame of the mouse desmoglein 6 transcript encodes a
precursor protein of 911 amino acid residues with a predicted
molecular weight of 100,516Da and isoelectric point of 4.84 (Fig 1).
As for desmoglein 5 this precursor comprises a 21 amino acid signal
sequence followed by a 28 amino acid prosequence that includes an
NXS/T glycosylation site and ends in a basic putative proteolysis
sequence RRQKR. Cleavage at this sequence would result in a mature
mouse desmoglein 6 unglycosylated peptide of 862 amino acids with
a molecular mass of 94,690Da and an isoelectric point of 4.68. As
well as the conserved RAL and putative Ca binding motifs (DXNDN
and A/VXDXD), there are three further potential N-glycosylation sites
(NXS/T), in EC1 that is conserved in all mouse desmogleins, in EC2 that
is conserved in desmoglcins 1, 3, and 5, and in EC4 that is not
conserved in any other mouse desmoglein (Fig 1). The cytoplasmic
domain of mouse desmoglein 6 contains a repeat unit domain with
four NV/ IXVT/RE repeats and a truncated terminal domain. The
identity at the protein level of mouse desmoglein 6 with mouse
desmoglein 1 (Mahoney et al, 2002) is 87%, with mouse desmoglein 2
(Mahoney et al, 2002) is 34%, with mouse desmoglein 3 (Ishikawa
et al, 2000) is 42%, with mouse desmoglein 4 is 44%, and with mouse
desmoglein 5 is 86% (Table V). The tissue expression profile for
desmoglein 6 demonstrates expression in epidermis, liver, and testis,
and in embryos at 17 d. Expression was not detected, however, in
whole brain, skeletal muscle, lung, heart, spleen, and kidney, or at
embryonic days 7–15 (Table VI).
Expression of mouse desmogleins 1–3
In addition to determining the tissue expression profiles of the new
mouse genes, RT-PCR using specific primers was also used to determine
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Table I. Exon–intron boundaries of the mouse desmoglein 4
gene DSG4
Exon
Exon
size (bp)
50 splice donor
sequence
Intron
size (bp)
30 splice donor
sequence
1 Noncoding+48 TTTATGgtaagt 9900 ttacagGTGGTA
2 36 GTTGAGgtaatg 531 ctttagGTAAAA
3 132 GCCAGAgtgagt 2259 ttgtagATTAGA
4 156 TTCCTGgtaagt 308 gcccagATCCAT
5 145 ACGCCAgtgagt 1924 ttatagATGCAC
6 167 AGAGAGgtaaag 1022 attaagCAACAC
7 135 ACCTCAgtaagt 1583 tttcagTACTCA
8 186 GTCAAGgtaagc 1957 tttcagATGCTG
9 272 TGTCAGgtatgt 1411 aaacagGTATGT
10 140 TAGATGgtaaga 2610 tttcagATGGCT
11 219 TCAATGgtaagt 926 ctccagGAACCT
12 306 TGCTCTgtaagt 2133 ggceagTGTCAC
13 140 GACAGGgtgagt 152 tttcagGATGTA
14 64 CATCTGgtcagt 1306 ttccagAAATCT
15 209 TCCGAGgtaagc 4149 tcttagAAAGCG
16 768+ noncoding
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the expression profiles of mouse desmogleins 1, 2, and 3. Results
demonstrate that desmoglein 1 is expressed in epidermis and testis, and
at embryonic days 15 and 17, but is not expressed in heart, whole brain,
spleen, lung, liver, skeletal muscle, kidney, or at embryonic days 7 or 11
(Table VI). Results for desmoglein 2 demonstrate expression in all tissues
tested (Table VI). Results for desmoglein 3 demonstrate expression in
epidermis and at embryonic days 7–17, but not in heart, whole brain,
spleen, lung, liver, skeletal muscle, kidney, or testis (Table VI).
Figure 1. Multiple amino acid sequence alignment of mouse desmogleins 1–6. Horizontal arrows above the amino acid sequence show the beginning of each
domain. Desmoglein 1 (Mahoney et al, 2002), desmoglein 2 (Mahoney et al, 2002), and desmoglein 3 (Ishikawa et al, 2000) are from published sequences.
Conserved motifs for all mouse isoforms are boxed and conserved amino acids are represented by asterisks (*) under the sequence. S, signal sequence;
p, preprotein domain; EC, extracellular domain; EA, extracellular anchor domain; TM, transmembrane domain; IA, intracellular anchor domain; ICS,
intracellular cadherin-typical segment domain; LD, linker domain; RUD, repeat unit domain; TD, terminal domain.
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Desmoglein gene organization demonstrates conservation between man
and mouse
The elucidation of the gene organization for the six mouse desmoglein
genes is useful in determining conservation with the human genes.
Mouse desmoglein 1 contains 15 exons (Mahoney et al, 2002) in
agreement with that determined for the human gene (Hunt et al, 2001),
although some reports have incorrectly determined that human
desmoglein 1 comprises only 14 exons (Rickman et al, 1999; Frank
et al, 2001). Both mouse and human desmoglein 2 comprise 15 exons
(Whittock, unpublished data), although a recent report incorrectly
demonstrated that the mouse gene comprised only 14 exons (Mahoney
et al, 2002) whereby exons 12 and 13 were combined to make exon 12.
The mouse and human desmoglein 3 genes (Frank et al, 2001) contain
16 exons, although some reports have stated that both contain only 15
exons (Silos et al, 1996; Koch et al, 1997; Ishikawa et al, 2000). Studies
have also now demonstrated that both human (Whittock and Bower,
2003) and mouse (Table I) desmoglein 4 genes comprise 16 exons. Exon
size conservation is also significant between the different genes. All of
the genes comprise an exon 2 of 36bp, exon 5 of 145bp, exon 6 of
167bp, and exon 8 of 186bp (Table VII). In addition, exon sizes are
conserved between desmogleins 3 and 4 for exons 1–6, 8–10, and 14.
We also demonstrate here that both mouse desmoglein 5 and mouse
desmoglein 6 comprise 15 exons (Tables II, III) although no human
homologs exist. Desmogleins 1, 5, and 6 share exon sizes for exons 1–6,
8, 10, and 13–14. Therefore, it can be deduced from these observations
that there is significant conservation of gene organization between
different isoforms and between human and mouse. It can be concluded
that the mouse desmoglein genes are a result through evolution of at
least two stages of gene duplication yielding four genes with 15 exons
and two genes with 16 exons.
Comparison of human and mouse desmoglein cluster arrangement
demonstrates evolutionary deletion of two mouse genes
The human desmoglein genes are clustered within a 250 kb (Fig 2)
region in the following order 50-DSG1-DSG4-DSG3-DSG2-30 (Simrak
et al, 1995; Whittock and Bower, 2003), whereas the mouse genes are
clustered within a 400 kb region in the order 50-DSG6-DSGl-DSG5-
DSG4-DSG3-DSG2-30 (Fig 2). The question therefore arises whether
mouse genes DSG6 and DSG5 were deleted during evolution through
two separate events or more plausibly whether mouse DSG5 is in fact
WHITTOCK
Table II. Exon–intron boundaries of the mouse desmoglein 5
gene DSG5
Exon
Exon
size (bp)
50 splice donor
sequence
Intron
size (bp)
30 splice donor
sequence
1 Non-coding+48 TCCCTGgtaagt 11159 ttacagGTGGTG
2 36 ATCCAGgtaaga 700 tttaagGTAAGA
3 132 GCCAAAgtaagt 1144 AtacagATTCAT
4 156 TTCATTgtaagt 1591 gtctagATCTAC
5 145 ATGCAAgtaagt 2305 ttctagACACAC
6 167 AGAGAGgtaatc 1455 tttcagCAATAT
7 135 TCATCTgtaagc 291 ttccagTATGAC
8 186 GTCAAGgtatgg 790 ttctagCGCCTA
9 260 TGTTAGgtaaga 304 atgcagATATGA
10 140 TAGATGgtaaga 1574 ttacagATTCCC
11 339 TAGGATgtaagt 5128 cttcagTGGTTG
12 137 CACGATgtaagt 310 ttttagGGGATA
13 73 ACTCAGgtaaga 2108 ttctagGAGTTT
14 209 TGCCAGgtaagg 996 aattagAAAGCC
15 1017+noncoding
Table III. Exon–intron boundaries of the mouse desmoglein 6
gene DSG6
Exon
Exon size
(bp)
50 splice donor
sequence
Intron size
(bp)
30 splice donor
sequence
1 Noncoding+48TCCCTGgtaagt 16812 ttacagGTGGTG
2 36 ATCGAGgtaaga 700 tttaagGTAAGA
3 132 GCCAAAgtaagt 1097 atacagATTCAT
4 156 TTCATTgtaagt 1601 gtctagATGTAT
5 145 ATGCAAgtgagt 2346 ttctagACACAC
6 167 AGAGAGgtaatc 1456 tttcagCAATAT
7 132 TGATCTgtaagc 291 ttccagTATGAC
8 186 GTCAAGgtatgg 2067 ttctagGCGCTA
9 269 TGTTAGgtaaga 297 ttttagATACAG
10 140 TACATGgtaaga 1581 ttacagATTCCC
11 186 TAGGATgtaagt 2136 cttcagTGGTTC
12 128 CCTGGTgtaagt 311 tttcagGGGATA
13 73 ACTGAGgtaaga 2124 ttctagGAGTTT
14 209 TGCGAGgtaagg 998 aattagAAAGCC
15 723 +
noncoding
Table IV. Nucleotide sequence homology of mouse
desmogleins 1–6
Dsg1 Dsg2 Dsg3 Dsg4 Dsg5 Dsg6
Dsgl 100 52 54 55 96 82
Dsg2 52 100 50 51 52 49
Dsg3 54 50 100 58 54 55
Dsg4 55 51 58 100 55 55
Dsg5 96 52 54 55 100 81
Dsg6 82 49 55 55 81 100
Mouse desmoglein 1, Mahoney et al (2002); mouse desmoglein 2,
Mahoney et al (2002); mouse desmoglein 3, Ishikawa et al (2000). Values
are expressed as percentage (%).
Table V. Amino acid sequence homology of mouse
desmogleins 1–6
Dsgl Dsg2 Dsg3 Dsg4 Dsg5 Dsg6
Dsg1 100 (100) 34 (50) 43 (57) 42 (57) 94 (95) 87 (89)
Dsg2 34 (50) 100 (100) 39 (55) 37 (53) 34 (50) 34 (49)
Dsg3 43 (57) 39 (55) 100 (100) 47 (64) 44 (57) 42 (54)
Dsg4 42 (57) 37 (53) 47 (64) 100 (100) 42 (56) 44 (58)
Dsg5 94 (95) 34 (50) 44 (57) 42 (56) 100 (100) 86 (88)
Dsg6 87 (89) 34 (49) 42 (54) 44 (58) 86 (88) 100 (100)
Mouse desmoglein 1, Mahoney et al (2002); mouse desmoglein 2,
Mahoney et al (2002); mouse desmoglein 3, Ishikawa et al (2000).
Values are expressed as percentage (%). Values in parentheses are
percentage similarity.
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the human homolog of DSG1. Nucleotide sequence homology for
mouse desmoglein 1 (Mahoney et al, 2002) and mouse desmoglein
5 with human desmoglein 1 (Nilles et al, 1991) is 79% for both
(Table VIII), and at the amino acid level is 78% for both with 85%
similarity (Table IX). Of note, homology of mouse desmoglein 6 with
human desmoglein 1 is 70 and 77% at the nucleotide and protein
levels, respectively (Tables VIII, IX), demonstrating that mouse
desmoglein 6 is not the homolog of human desmoglein 1. In addition,
comparison of the mouse and human promoters reveals high
homology for mouse desmogleins 1 and 5 with human desmoglein 1
(not shown). Therefore, because of this very high homology of mouse
desmoglein 1 and 5 with human desmoglein 1 at the protein, transcript,
gene, and promoter level it is very difficult to make a conclusion. In
addition, the transcript expression profiles of mouse desmoglein 1 and
mouse desmoglein 5 are not too dissimilar (Table VI). Of the tissues
screened, mouse desmoglein 1 is expressed in epidermis and testis and at
embryonic days 15 and 17, whereas mouse desmoglein 5 is expressed in
epidermis and at mouse embryonic day 17. Arguments regarding the
immunolocalization of mouse desmoglein 1 must now be questioned as
the epitopes recognized by the antibodies used most probably cross-react
with not only desmoglein 5 but mouse desmoglein 6 as well. New
antibodies are required that exploit the minor amino acid sequences
between these new desmogleins in order to correctly determine the
cellular localizations of these proteins. In conclusion, based on the gene
clusters of man and mouse it is more likely that mouse desmoglein 5 is the
true genetic homolog of human desmoglein 1, and that the two
centromeric genes, now known as DSG6 and DSG1, were deleted from
the desmocollin/dcsmoglein interlocus region.
Comparison of mouse desmoglein isofbrms at the protein level
demonstrate significant homology
Protein sequence comparison (Figs 1, 3) demonstrates that all mouse
desmogleins contain a 21 residue signal sequence to direct them to the
endoplasmic reticulum. The proscquence comprises 28 residues for
isoforms 1 and 3–6, and 32 residues for isoform 2, all of which end in a
five-residue cleavage recognition site with a consensus (R/V)R(Q/Y)KR.
All of the mature proteins contain a tryptophan residue at position 2
and a potential N-glycosylation site (NXS/T) in EC1. The conserved
tripeptide sequence in desmogleins 1 and 3–6 comprises Arg-Ala-Lcu,
whereas desmoglein 2 comprises Tyr-Ala-Leu. Putative Ca2þ binding
motifs (DXNDN and A/VXDXD) are conserved in all desmogleins at
the end of ECl, the beginning and end of EC2, the beginning of EC3,
and the beginning of EC4, although some conservative substitutions
have occurred within the latter motif for desmoglein 6 (ATDCE). The
EA domain demonstrates the least homology between the different
mouse isoforms and is therefore ideal for exploitation in raising
isoform-specific antibodies. Each isoform contains a 25 residue
transmembrane domain followed by conserved intracellular anchor
and intracellular cadherin segments. The repeat unit domains
comprise repeats of approximately 30 residues containing the
consensus sequence (N)(V/I/Y)(X)(V/L/Y)(T/A/R)(E). Desmogleins 1
and 5 contain five repeats, desmoglein 6 contains four repeats, and
Table VI. Isoforms of desmoglein in different mouse tissues
as detected by RT-PCR
Tissue Dsg1 Dsg2 Dsg3 Dsg4 Dsg5 Dsg6
Epidermis + + + + + +
Heart  +    
Whole brain  +    
Spleen  +    
Lung  +    
Liver  +    +
Skeletal muscle  +    
Kidney  +    
Testis + +    +
7 d embryo  + + +  
11 d embryo  + + +  
15 d embryo + + + +  
17 d embryo + + + + + +
Table VII. Comparison of the deduced exon sizes for the six mouse desmoglein genes
Exon DSG1 DSG2 DSG3 DSG4 DSG5 DSG6
1 Non-coding+48 Non-coding+60 Non-coding+48 Non-coding+48 Non-coding+48 Noncoding+48
2 36 36 36 36 36 36
3 132 135 132 132 132 132
4 156 162 156 156 156 156
5 145 145 145 145 145 145
6 167 167 167 167 167 167
7 135 138 129 135 135 132
8 186 186 186 186 186 186
9 260 266 272 272 260 269
10 140 143 140 140 140 140
11 330 228 228 219 339 186
12 137 228 255 306 137 128
13 73 122 143 140 73 73
14 209 330 64 64 209 209
15 1017+coding 1020+noncoding 221 209 1017+noncoding 723+noncoding
16 657+noncoding 768+noncoding
DSG1, Mahoney et al (2002); DSG2 and DSG3, Whittock (unpublished data).
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desmogleins 3 and 4 contain two repeats. Human desmoglein 2 has
been stated to contain six repeats (Schmidt et al, 1994) although the
mouse homolog contains only two repeats that fit the consensus.
Several very close motifs exist within mouse desmoglein 2, however
(SLIVTE and KVLVTE), predicting that it may contain four repeats.
Comparison of the overall sizes of the preproteins and mature proteins
by residue content and molecular weight demonstrates that mouse
desmoglein 2 is the largest of the isoforms (Table X) whereas
desmoglein 6 is the smallest. In addition calculation of the isoelectric
points for the isoforms demonstrates that desmoglein 2 has the most
basic content whereas desmoglein 4 has the most acidic content,
although all mature proteins have an isoelectric point in the range
4.55–5.01 (Table X).
GenBank accession number
Mouse desmoglein 4, 5, and 6 cDNA sequences have been deposited
in the GenBank sequence database under Accession nos. AY191584,
AY192158, and AY192159, respectively.
DISCUSSION
Here, we have demonstrated the presence of three new transcribed
desmoglein genes, namely the mouse homolog of human dcsmoglein
4 and two novel mouse dcsmoglein isoforms that we term desmoglein
5 and desmoglein 6, and we show that they lie in a cluster of six genes.
The identification of at least one additional desmoglein gene is not
surprising as evidence has been obtained for at least one gene with
homology to desmoglein 1 in the past (Puttagunta et al, 1994). Whilst
isolating the bovine dcsmoglein 1 gene, evidence was found of
polymorphism within the extracellular anchor domain. It is therefore
likely that, as well as isolating bovine desmoglein 1, a bovine
desmoglein 5 homolog had also been identified, although the authors
could not conclude whether this region of polymorphism was allelic
or represented a different gene (Puttagunta et al, 1994). It is unlikely
that only bovine and now mouse species have additional desmoglein
genes and it can therefore be concluded from these studies that a large
number of species have at least one close homolog of desmoglein 1.
The question then arises why some species have more genes and
therefore more desmoglein proteins within their skin than in humans. Is
this due to the fact that the living environment tor these animals is
harsher and their skin is required to be tougher? Indeed, studies may
show that species from an evolutionary earlier period have more than six
desmoglein genes. Further studies on a wide range of species will be
required to answer these questions.
The tissue expression of the mouse desmoglein isoforms during
embryonic development may cast some light on their specific roles
during gestation. Whereas mouse isoforms 2, 3, and 4 are expressed as
early as 7 d gestation, isoform 1 is not expressed until gestational day
15, and isoforms 5 and 6 are not expressed until day 17
(Table VI). Stratification of the mouse body epidermis commences at
around embryonic day 13.5 when it beconres mul-tilayered, and by
embryonic day 14.5 the ventral epidermis is clearly stratified (King
et al, 1996). Previous studies have shown that the expressions of
desmoglein 1 as well as desmocollin 1 are closely related to
keratinization of the epidermis (King et al, 1996). We have shown
that transcripts for all six desmoglein isoforms are present in mouse
epidermis and it therefore appears that the expression of mouse
desmoglein isoforms 5 and 6 may well be closely related to
keratinization of the epidermis and may indicate-that desmogleins 5
and 6 are expressed in the superficial layers along with desmoglein 1.
The expressions of isoforms 2, 3, and 4, however, are linked with a
much earlier process during mouse development, most probably the
development of the basal cell layer of the epidermis, which may
indicate that desmoglein 4 protein is expressed within the basal and
immediate suprabasal cell layers along with desmoglein 3.
The involvement of the desmoglein isoforms has been implicated
in human inherited and autoimmune disease as well as microbial
WHITTOCK
Figure 2. Schematic representation of the mouse and human desmoglein clusters.Mouse DSG6 lies centromeric to DSG1, with DSG5 and DSC4 between DSG1
and DSG3, with the entire mouse desmoglein complex occupying approximately 400kb. The human desmoglein cluster occupies approximately 250kb of 18q12.
Table VIII. Nucleotide sequence homology of mouse
desmogleins 1, 5, and 6 with human desmoglein 1
Mouse dsg1 Mouse dsg5 Mouse dsg6 Human dsg1
Mouse dsg1 100 96 82 79
Mouse dsg5 96 100 81 79
Mouse dsg6 82 81 100 70
Human dsg1 79 79 70 100
Mouse desmoglein 1, Mahoney et al (2002); human desmoglein 1, Nilles
et al (1991).
Values are expressed as percentage (%).
Table IX. Amino acid sequence homology of mouse
desmogleins 1, 5, and 6 with human desmoglein 1
Mouse dsg1 Mouse dsg5 Mouse dsg6 Human dsg1
Mouse dsg1 100 (100) 94 (95) 87 (89) 78 (85)
Mouse dsg5 94 (95) 100 (100) 86 (88) 78 (85)
Mouse dsg6 87 (89) 86 (88) 100 (100) 77 (83)
Human dsg1 78 (85) 78 (85) 77 (83) 100 (100)
Mouse desmoglein 1, Mahoney et al (2002); human desmoglein 1, Nilles
et al (1991).
Values are expressed as percentage (%).
Values in parentheses are percentage similarity.
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attack, all of which lead to loss of cell–cell adhesion. Striate
palmoplantar keratoderma (MIM 148700) (Siemens, 1929; El Sayed
and Bazcx, 1993) is an autosomal dominant genoderma-tosis
characterized clinically by the development of linear and focal
hyperkeratosis of the palms and soles during the first or second decade
(Griffiths et al, 1998; Armstrong et al, 1999). The majority of cases of
striate palmoplantar keratoderma are due to mutations within the
extracellular domain of desmoglein 1 that lead to haploinsufficiency of
the protein (Rickman et al, 1999; Hunt et al, 2001; Kljuic et al, 2003).
Pemphigus foliaccus, fogo sel-vagem (endemic pemphigus foliaceus),
and pemphigus vulgaris are autoimmune disorders characterized by
blisters and erosions of the skin (Lever, 1965; Diaz et al, 1989). In
pemphigus foliaceus and fogo selvagem the blisters occur beneath the
stratum cor-ncum, whereas in pemphigus vulgaris the blistering is
intracpi-dcrmal, occurring above the basal layer and with additional
involvement of the mucous membranes. The autoantigens recognized
by the circulating antibodies and T cells in pemphigus foliaceus and
fogo selvagem have been identified as dcsmoglein 1, whereas those in
pemphigus vulgaris recognize desmoglein 3 (Stanley et al, 1984; Labib
et al, 1990; Amagai et al, 1991; Oursler et al, 1992; Olague-Alcala et al,
1994; Emery et al, 1995; Lin et al, 1997a; 1997b, 2000). Studies have
shown that the autoantibodies in some patients with pemphigus
foliaceus (7%) and pemphigus vulgaris (50%), however, recognize both
dcsmoglein 1 and desmoglein 3 isoforms (Lin et al, 1997a; Arteaga et al,
2002), and in some cases patients can progress front pemphigus vulgaris
to pemphigus foliaccus or vice versa, although the latter is less common
(Iwatsuki et al, 1991; Kawana et al, 1994; Chang et al, 1997; Ishii et al,
2000). Staphylococcal scalded skin syndrome, also known as pemphi-
gus nconatorunr, dermatitis exfoliativa neonatorum, or Ritter0s disease,
is a generalized skin blistering disease primarily affecting infants and
young children. Clinically the disease is characterized by fever, skin
tenderness, and erythema with the subsequent loss of large areas of skin
due to epidermal separation that occurs in days or even hours of onset.
This blistering disease is induced by at least three serotypes of
exfoliative toxin (ET) of Staphylococcus aureus, namely ETA, ETB, and
ETD (Melish and Glasgow, 1970; Melish et al, 1972; Hanakawa et al,
2002b). Studies have concluded that the various strains of S. aureus
produce their specific toxins in the skin, whereby they target and cleave
the epidermal differentiation-specific desmoglein iso-form, desmoglein
1 (Amagai et al, 2000, 2002; Hanakawa et al, 2002b). This direct
cleavage occurs within the extracellular domain of the protein resulting
in dysadhesion between neighboring keratinocytes, thereby destroying
the protective barrier of the stratum corneum and allowing the bacteria
to enter and flourish within the skin.
As mentioned above the only human desmoglein disease model is
the involvement of desmoglein 1 in striate palmoplantar ker-atoderma.
No mouse desmoglein 1 models have been successfully engineered to
date, however. The sequence homology and expression profile data
for desmogleins 5 and 6 make it abundantly clear that any attempt to
knock out desmoglein 1 probably results in compensation by
desmogleins 5 and 6 within the epidermis. Therefore, methods must
be employed to knock out the dcsmoglcin 1, 5, and 6 genes in order to
yield a mouse with a superficial epidermal phenotype similar to that of
striate palmoplantar kera-toderma. When antibodies that cause human
pemphigus foliaccus are injected into mouse skin, however, neither
desmoglein 5 nor desmoglein 6 can compensate for the antibody-
induced loss of desmoglein 1 as its protein sequence is nearly identical
at the predicted antigenic sites, thus resulting in the expected
pemphigus foliaceus blistering phenotype. It can also be predicted
from homology at the protein level that desmoglein 5 may also be a
target for the different forms of exfoliative toxins. These toxins cleave
human and mouse desmoglein 1 at a unique site after a glutamic acid
residue (i.e., E381 for both human and mouse desmoglein 1) at the
carboxy end of extracellular domain 3 (Hanakawa et al, 2002b).
Indeed, around this cleavage site the amino acid sequence of mouse
desmoglein 5 is identical to that of mouse desmoglein 1; however, this
sequence is different for mouse desmoglein 6, which lacks the
glutamic acid residue. Desmoglein 6 may therefore convey some
resistance for the mouse against attack by S. aureas.
Of the desmoglein isoforms, desmoglein 3 has been the most
widely studied isoform and several mouse models have been
constructed. Desmoglein 3 knockout mice demonstrate a loss of
keratinocyte cell–cell adhesion that results in a phenotype resembling
that of patients with pemphigus vulgaris (Koch et al, 1997).
Specifically, the oral mucosa demonstrates the full range of lesions
seen in individuals with pemphigus vulgaris in addition to suprabasal
blisters in traumatized skin. Knockout mice are smaller in size
compared with wild-type and heterozygous knockout mice and
demonstrate a remarkable decrease in body fat. In addition, after 3–4
wk the mice become bald with a very similar phenotype to balding
(bal) mice. Subsequent studies have shown that two naturally occurring
autosomal recessive balding (bal and dsg3bal-pas) mice have protein
truncating mutations in desmoglein 3 that result in the loss of their
cytoplasmic domain (Koch et al, 1997; Choi et al, 2002). A desmoglein
isoform compensation hypothesis has been derived based on several
observations (Udey and Stanley, 1999). Neonates of mothers affected
with pemphigus foliaceus appear to be protected against the maternal
circulating antibodies against desmoglein 1 (Wu et al, 2000). The
expression of desmoglein 3 in neonatal skin is different to that of human
adult skin (Wu et al, 2000). In neonates desmoglein 3 is expressed
throughout the epidermis whereas, as mentioned above, the expression
in adult skin is in the deep epidermis. It therefore seems that the
desmoglein 3 expression in the superficial layers of the neonate can
compensate for the loss of antibody-induced loss of desmoglein 1. In
adult skin, however, desmoglein 3 expression is not present in the
superficial layers and hence patients develop blisters throughout the
superficial epidermis. The induction of desmoglein 3 expression
throughout the superficial epidermis is a very obvious target for gene
therapy in patients with pemphigus foliaceus. In another study, it has
been demonstrated that expression of desmoglein 1 can compensate for
the genetic loss of desmoglcin 3 in keratinocyte adhesion (Hanakawa
et al, 2002a). Here, the authors directed expression of desmoglein 1
using a keratin 14 promoter in desmoglein 3 knockout mice and studied
whether these mice lost their telogen hair prematurely. Although there
was some increased hair loss desmoglein 1 could compensate to a
certain degree for the lack of desmoglein 3 in the desmosomes
(Hanakawa et al, 2002a). Very recently, a mouse desmoglein 2
knockout model has been engineered using homologous recombination
(Eshkind et al, 2002). Both homozygous and a significant number of
heterozygous knockout mice died shortly after implantation (Eshkind
et al, 2002).
Another question that arises with the discovery of three further
desmogleins is what their desmocollin binding partners are. A
simplistic model based on the expression profiles of these proteins
and some binding experiments predicts that desmoglein 1 interacts
with desmocollin 1, desmoglein 2 interacts with desmocollin 2, and
desmoglein 3 interacts with desmocollin 3. Studies are now required,
however, to determine the partners of desmoglcins 4, 5, and 6.
Previous studies have shown that desmogleins form weak homophilic
interactions (Syed et al, 2002) so it can be concluded based on
predicted expression patterns that desmoglein 4 probably interacts
with desmocollin 3 within the basal and immediate suprabasal cells,
and that desmoglcins 5 and 6 interact with desmocollin 1 in the
superficial layers.
Apart from their adhesive capacity, do the dcsmosomal cadher-ins
perform any additional roles? In a recent study to determine what might
happen when a desmosomal cadherin is expressed out of its correct cell
layer Ishii et al (2001) discovered by expression of ectopic desmosomal
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cadherins that epithelial cells can tolerate large ranges in the amounts of
endogenous dcsmosomal cadherins, but that low levels expressed out of
their normal cellular context (i.e., desmoglein 1) can disrupt desmo-
somes. They concluded that there must be a specific program of
differentiation in which the spatial and temporal expression pattern of
the differentiation-specific dcsmosomal cadherins (i.e., desmoglein 1
and desmocollin 1) is coordinated with that of their binding partners,
which facilitate their incorporation into desmosomes (Ishii et al, 2001).
In another study to determine whether the distribution of the different
dcsmoglcin isoforms affected the structure or function of the epidermis,
transgenic mice were bred with desmoglein 3 driven by the involucrin
promoter to express the transgcnc in the superficial epidermis (Elias et al,
2001). These mice demonstrated an abnormal stratum corneum that was
more like that of mucous membranes and showed an abnormal skin
barrier function characterized by increased transcpidcrmal water loss
(Elias et al, 2001). It can therefore be concluded from all of these studies
that, in addition to the obvious interchangeable adhesive role of the
desmoglein isoforms, their relative ratios within any layer in the skin
dictate the precise structure and function of those keratinocytes.
Interestingly, RT-PCR demonstrated that desmoglein 2 was widely
expressed in desmosome and nondesmosome containing tissues
(Table VI). Could this be due to the oversensitive nature of the RT-PCR
used or docs desmoglein 2 play an important role in nondesmosomal
tissues? Recent studies have shown that desmoglein 2 is essential for the
inner cell mass of blastocysts and the embryonal stem cell population
derived from them (Eshkind et al, 2002). These authors have shown that
desmoglein 2 is located in desmoplakin-negative wild-type embryonal
stem cells in nondesmosomal junctions and demonstrate that it is
required for normal embryonal stem cell proliferation (Eshkind et al,
2002). Therefore, it can be concluded that desmoglein 2 may play a
much larger role in mouse development than just as an attachment
molecule.
In summary, we have demonstrated that there are six mouse
desmoglein genes. Studies are now required to determine the
expression profile of these isoforms at the protein level, to determine
their binding partners, and to use recombinant mouse technology in
order to determine the essential roles of the proteins. These results may
have some impact on the desmoglein compensation hypothesis in
mouse and in addition may have some value in human gene therapy in
diseases such as pemphigus.
ELECTRONIC DATABASE INFORMATION
URLs for data in this article are as follows: Online Mendelian
Inheritance in Man (OMIM), http://www3.ncbi.nhn.nih.gov/Omim/
Human Genome Working Draft, http://genome.ucsc.edu/
The Protein Machine, http://www2.ebi.ac.uk/ Biology WorkBcnch
3.2, http://biowb.sdsc.edu/
Expert protein analysis system, http://us.expasy.org/
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Figure 3. Schematic representation of the six mouse encoded proteins. Each isoform comprises a signal (S) and preprotein (p) domain followed by five
extracellular domains (EC1–4, EA), a transmembrane domain (TM), an intracellular anchor domain (IA), an intracellular cadherin-typical segment domain (ICS), a
linker domain (LD), a repeat unit domain (RUD) containing various repeats, and a terminal domain (TD).
Table X. Molecular weight and isoelectric points for precursor and cleaved mature mouse desmoglein isoforms
Precursor proteins Cleaved proteins
Isoform
Number of
amino acids
Molecular
weight (Da)
Isoelectric
point (pi)
Number of
amino acids
Molecular
weight (Da)
Isoelectric
point (pi)
Dsg1 1057 114,597 4.78 1008 108,771 4.64
Dsg2 1122 122,385 5.16 1068 116,324 5.01
Dsg3 993 107,902 4.82 944 102,448 4.67
Dsg4 1041 114,449 4.58 992 108,598 4.55
Dsg5 1060 114,454 4.72 1011 108,628 4.59
Dsg6 911 100,516 4.84 862 94,690 4.68
Mouse desmoglein 1, Mahoney et al (2002); mouse desmoglein 2, Mahoney et al (2002); mouse desmoglein 3, Ishikawa et al (2000).
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